Showing results (781-790 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|August 10, 2026
Evaluating the cognitive efficacy of marine-derived drugs in Alzheimer's disease: A systematic review and Bayesian network meta-analysisZhaoming Song, Yun Xie, Hanmo Zhu, et al.
Therapeutic Advances in Neurological Disorders|August 13, 2026
Current practices in delirium prevention and treatment after acute stroke: results of a multicentre surveyMarkus Kneihsl, Annerose Mengel, Stefan Sumerauer, et al.
Therapeutic Advances in Neurological Disorders|September 2, 2026
The association between BMI and cognition, disability, and quality of life markers in multiple sclerosis: DISCOMS secondary analysisAliza Bitton Ben-Zacharia, Gary Cutter, Alya Shor, et al.
Therapeutic Advances in Neurological Disorders|September 7, 2026
Patient SAtisfaction with the TYSabri SC Formulation - A Swiss multi-centriC, prospective non-intervenTIONal study: the SATYSFACTION studyChiara Zecca, Guilio Disanto, Gianna Carla Riccitelli, et al.
Therapeutic Advances in Neurological Disorders|September 13, 2026
Spinal muscular atrophy: Biology, pathogenesis, and therapeutic advancesCharlotte A René, Robin J Parks
Therapeutic Advances in Neurological Disorders|September 13, 2026
Telitacicept for primary angiitis of the central nervous system: A real-world retrospective studyJiangyi Lyu, Yifan Wang, Fangfang Li, et al.
Therapeutic Advances in Neurological Disorders|October 26, 2020
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and SwedenKatja Marja Hakkarainen, Rosa Juuti, Sarah Burkill, et al.
Therapeutic Advances in Neurological Disorders|July 15, 2021
A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimodAmber Salter, Samantha Lancia, Gary Cutter, et al.
Therapeutic Advances in Neurological Disorders|December 26, 2022
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score-matched studyKatrin Pape, Leoni Rolfes, Falk Steffen, et al.
Therapeutic Advances in Neurological Disorders|June 24, 2021
7T MRI with post-processing for the presurgical evaluation of pharmacoresistant focal epilepsyCong Chen, Juan-Juan Xie, Fang Ding, et al.
Pageof 108